Pfizer and BioNTech ask US regulator to authorise variant-specific jab
Vaccine targeting BA.4/BA.5 could become first shot to win green light without human trials
版權(quán)聲明：本文版權(quán)歸FT中文網(wǎng)所有，未經(jīng)允許任何單位或個(gè)人不得轉(zhuǎn)載，復(fù)制或以任何其他方式使用本文全部或部分，侵權(quán)必究。